Navigation Links
Cellectricon Launches Dynaflow® Resolve System Enabling Novel Ion Channel Assays
Date:3/22/2012

GOTHENBURG, Sweden, March 22, 2012 /PRNewswire/ --

The new Dynaflow Resolve System was developed in close collaboration with leading ion-channel research groups to meet the demand for a simpler technology capable of complex perfusion protocols. The Dynaflow Resolve System is an advanced automated perfusion system that enables novel experimental protocols by allowing recording of any ion channel current, using any cell type, and any compound. The new and improved system retains all the advantages from the previously validated Dynaflow technology and now features the Resolve Glass Chip, providing reusability and adsorption-free perfusion.

"We are very impressed and happy with the data quality the Dynaflow Resolve Glass Chip is providing, both from cell lines and acutely isolated striatal neurons." says Ari-Pekka Koivisto, PhD, Orion Pharma, Finland.

The Dynaflow Resolve chip is made out of glass and has been developed based on customer requirements to minimize adsorption of highly hydrophobic compounds. Besides complete experimental freedom the chip offers reusability and improved cost-efficiency.

"The Dynaflow Resolve chip has solved our problems with difficult compounds and also offers complete flexibility well controlled perfusion and reusability with easy cleaning." Jessica Strömberg, PhD, Umecrine, Umeå, Sweden.

With the launch of the improved Dynaflow Resolve Glass Chip and System, Cellectricon will discontinue the production of the disposable plastic chips by the end of June 2012. Cellectricon offers new and existing customers the ability to take advantage of the benefits of this new technology.

About Cellectricon

Cellectricon, is a leading provider of advanced compound screening technologies and services to accelerate drug discovery and cell-based assay research. Our proprietary technologies include leading systems for high resolution ion-channel screening and cell engineering. Developed in close collaboration with leaders in the pharmaceutical industry and esteemed research labs, the Cellaxess® Technology enables scalable  field stimulation, compound delivery and transfection for genomic screening of primary cells, neurones and stem cells. The Dynaflow® Technology advances ion channel research and discovery applications.

http://www.cellectricon.com


'/>"/>
SOURCE Cellectricon
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cellectricon Receives Milestone Order for Cellaxess(R)HT, the Worlds First High Throughput RNAi Screening System
2. Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market.
3. Cellectricon and BioFocus DPI Advance High Throughput ion Channel Drug Discovery
4. Cellectricon Files Patent Infringement Suit Against Fluxion Biosciences
5. David Burns Appointed CEO/President of Cellectricon
6. Hooper Holmes Heritage Labs Division Launches New Home Diabetes Test
7. ICON Medical Imaging Launches New Service to Boost Reliability of Cardiology Studies
8. StollerUSA Launches Bio-Forge.com to Offer Solutions for Crops Under Stress
9. GEECF: Spectrum Launches Zero Waste Philippines and Gears Towards Cheap Green Energy
10. ETEX Launches Innovative Osteoinductive Orthobiologic, EquivaBone(TM)
11. ChemAxon Launches Marvin and JChem Version 5.1; Name to Structure Generation, OLE 2 and JavaScript Integration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... again at the CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency Miami, ... panel discussions to examine vital clinical research issues such as trial performance metrics, ...
(Date:1/18/2017)... ... January 18, 2017 , ... uBiome, the ... paper by its Science Editor, Dr. Elisabeth Bik, in the December 2016 issue ... Bik joined uBiome in October 2016 from her previous position at Stanford University ...
(Date:1/18/2017)... Jan. 18, 2017 Shareholder rights law firm ... whether the board members of CoLucid Pharmaceuticals, Inc. (NASDAQ: ... connection with the proposed sale of the Company to ... that develops small molecules for the acute treatment of ... it had signed a definitive merger agreement with Eli ...
(Date:1/18/2017)... IRVING, Texas , Jan. 18, 2017 /PRNewswire/ ... science, and the Lustgarten Foundation, the largest private ... support a clinical trial evaluating the impact of ... is providing clinical trial enrollment services to identify ... and facilitate communication between treating physicians and study ...
Breaking Biology Technology:
(Date:1/19/2017)... PUNE, India , January 19, 2017 ... Sensor Market, Opportunities and Forecast, 2014 - 2022," the global biometric sensor ... of 9.6% from 2016 to 2022. In 2015, Asia-Pacific ... for both public and private sectors. Continue Reading ... ...
(Date:1/19/2017)... 19, 2017 Sensory Inc ., ... security for consumer electronics, and i ... and cybersecurity solutions, today announced a global partnership ... institutions worldwide to bolster security of data sensitive ... user authentication platforms they offer, innerCore now offers ...
(Date:1/18/2017)... Jan. 18, 2017  In vitro diagnostic (IVD) companies ... and acquisitions (M&A), and Kalorama Information expects that trend ... have been shifting. Generally, uncertainty in reimbursement and healthcare ... U.S. has changed the acquisitions landscape. Instead of looking ... companies buying partners outside of their home country and ...
Breaking Biology News(10 mins):